AMBER PURDY: Open Payments
NPI 1417509647 · HUNTINGDON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 59 payments from 9 companies in 2025. Trend: 2023 $949 · 2024 $762 · 2025 $831
Food & beverage: $831
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $396 |
| PFIZER INC. | 12 | $186 |
| Novo Nordisk Inc | 5 | $82 |
| Lilly USA, LLC | 3 | $50 |
| GlaxoSmithKline, LLC. | 2 | $46 |
| Dexcom, Inc. | 1 | $19 |
| Abbott Laboratories | 1 | $19 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: QULIPTA, NURTEC ODT, VRAYLAR, UBRELVY, Ozempic, SHINGRIX, MOUNJARO, PAXLOVID.
Industry payments across PA — which companies pay providers there.
